Genetic analysis of the DLGAP1 gene as a candidate gene for schizophrenia

Psychiatry Research

Volumn 205, Issue 1-2, 2013, Pages 13-17

  Li, Jun Ming ^a   Lu, Chao Lin ^b   Cheng, Min Chih ^c   Luu, Sy Ueng ^a   Hsu, Shih Hsin ^c   Chen, Chia Hsiang ^d,e,f  

^a TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c YULI VETERANS HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

DLGAP1; Gene; Rare mutation; Schizophrenia

Indexed keywords

ARGININE; LYSINE; POSTSYNAPTIC DENSITY PROTEIN 95; POSTSYNAPTIC DENSITY PROTEIN 95 ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; CHINESE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LARGE DROSOPHILA HOMOLOG ASSOCIATED PROTEIN 1 GENE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TAIWAN;

EID: 84872618077     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.08.014     Document Type: Article

References (30)

1. Aoyama S., Shirakawa O., Ono H., Hashimoto T., Kajimoto Y., Maeda K. Mutation and association analysis of the DAP-1 gene with schizophrenia. Psychiatry and Clinical Neurosciences 2003, 57:545-547.
2. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics 2000, 97:12-17.
3. Craddock N., O'Donovan M.C., Owen M.J. Phenotypic and genetic complexity of psychosis. The British Journal of Psychiatry 2007, 190:200-203.
4. den Dunnen J.T., Paalman M.H. Standardizing mutation nomenclature: why bother?. Human Mutation 2003, 22:181-182.
5. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.-C., de Mas P., Bieth E., Roge B., Heron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics 2007, 39:25-27.
6. Frank R.A.W., McRae A.F., Pocklington A.J., van de Lagemaat L.N., Navarro P., Croning M.D.R., Komiyama N.H., Bradley S.J., Challiss R.A.J., Armstrong J.D., Finn R.D., Malloy M.P., MacLean A.W., Harris S.E., Starr J.M., Bhaskar S.S., Howard E.K., Hunt S.E., Coffey A.J., Ranganath V., Deloukas P., Rogers J., Muir W.J., Deary I.J., Blackwood D.H., Visscher P.M., Grant S.G.N. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS One 2011, 6:e19011.
7. Funk A.J., Rumbaugh G., Harotunian V., McCullumsmith R.E., Meador-Woodruff J.H. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport 2009, 15:1019-1022.
8. Gauthier J., Champagne N., Lafrenière R.G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., CÔté M., Noreau A., Hamdan F.F., Addington A.M., Rapoport J.L., DeLisi L.E., Krebs M.-O., Joober R., Fathalli F., Mouaffak F., Haghighi A.P., Néri C., Dubé M.-P., Samuels M.E., Marineau C., Stone E.A., Awadalla P., Barker P.A., Carbonetto S., Drapeau P., Rouleau G.A., Team t.S.D. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7863-7868.
9. Gauthier J., Spiegelman D., Piton A., Lafrenière R.G., Laurent S., St-Onge J., Lapointe L., Hamdan F.F., Cossette P., Mottron L., Fombonne É., Joober R., Marineau C., Drapeau P., Rouleau G.A. Novel de novo SHANK3 mutation in autistic patients. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics 2009, 150B:421-424.
10. Goff D.C., Wine L. Glutamate in schizophrenia: clinical and research implications. Schizophrenia Research 1997, 27:157-168.
11. Kajimoto Y., Shirakawa O., Lin X.-H., Hashimoto T., Kitamura N., Murakami N., Takumi T., Maeda K. Synapse-Associated Protein 90//Postsynaptic Density-95-Associated Protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia. Neuropsychopharmacology 2003, 28:1831-1839.
12. Kawashima N., Takamiya K., Sun J., Kitabatake A., Sobue K. Differential expression of isoforms of PSD-95 binding protein (GKAP/SAPAP1) during rat brain development. FEBS Letters 1997, 418:301-304.
13. Kim E., Naisbitt S., Hsueh Y.-P., Rao A., Rothschild A., Craig A.M., Sheng M. GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. Journal of Cell Biology 1997, 136:669-678.
14. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 17:234-239.
15. McClellan J.M., Susser E., King M.-C. Schizophrenia: a common disease caused by multiple rare alleles. British Journal of Psychiatry 2007, 190:194-199.
16. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry 2000, 57:637-648.
17. Moessner R., Marshall C.R., Sutcliffe J.S., Skaug J., Pinto D., Vincent J., Zwaigenbaum L., Fernandez B., Roberts W., Szatmari P., Scherer S.W. Contribution of SHANK3 mutations to autism spectrum disorder. American Journal of Human Genetics 2007, 81:1289-1297.
18. Mukherjee O., Meera P., Ghosh S., Kubendran S., Kiran K., Manjunath K.R., Subhash M.N., Benegal V., Brahmachari S.K., Majumder P.P., Jain S. Evidence of linkage and association on 18p11.2 for psychosis. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics 2006, 141B:868-873.
19. Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J., Weinberg R.J., Worley P.F., Sheng M. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 1999, 23:569-582.
20. Ohnuma T., Kato H., Arai H., Faull R.L., McKenna P.J., Emson P.C. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 2000, 28:3133-3137.
21. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research 1999, 33:523-533.
22. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., Ekholm J., Cichon S., Turecki G., Claes S., Kelsoe J.R., Schofield P.R., Badenhop R.F., Morissette J., Coon H., Blackwood D., McInnes L.A., Foroud T., Edenberg H.J., Reich T., Rice J.P., Goate A., McInnis M.G., McMahon F.J., Badner J.A., Goldin L.R., Bennett P., Willour V.L., Zandi P.P., Liu J., Gilliam C., Juo S.-H., Berrettini W.H., Yoshikawa T., Peltonen L., Lönnqvist J., Nöthen M.M., Schumacher J., Windemuth C., Rietschel M., Propping P., Maier W., Alda M., Grof P., Rouleau G.A., Del-Favero J., Van Broeckhoven C., Mendlewicz J., Adolfsson R., Spence M.A., Luebbert H., Adams L.J., Donald J.A., Mitchell P.B., Barden N., Shink E., Byerley W., Muir W., Visscher P.M., Macgregor S., Gurling H., Kalsi G., McQuillin A., Escamilla M.A., Reus V.I., Leon P., Freimer N.B., Ewald H., Kruse T.A., Mors O., Radhakrishna U., Blouin J.-L., Antonarakis S.E., Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part III: bipolar disorder. American Journal of Human Genetics 2003, 73:49-62.
23. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research 2005, 15:97-98.
24. Stephan K.E., Baldeweg T., Friston K.J. Synaptic plasticity and dysconnection in schizophrenia. Biological Psychiatry 2006, 59:929-939.
25. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Möller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Mühleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nöthen M.M., Peltonen L., Collier D.A., Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 11:232-236.
26. Takeuchi M., Hata Y., Hirao K., Toyoda A., Irie M., Takai Y. SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. Journal of Biological Chemistry 1997, 272:11943-11951.
27. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 25:539-543.
28. Xu B., Roos J.L., Dexheimer P., Boone B., Plummer B., Levy S., Gogos J.A., Karayiorgou M. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nature Genetics 2011, 43:864-868.
29. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nature Genetics 2008, 40:880-885.
30. Yao I., Hata Y., Hirao K., Deguchi M., Ide N., Takeuchi M., Takai Y. Synamon, a novel neuronal protein interacting with synapse-associated protein 90/postsynaptic density-95-associated protein. Journal of Biological Chemistry 1999, 274:27463-27466.